Crosstalk of the insulin-like growth factor receptor with the Wnt signaling pathway in breast cancer
The insulin-like growth factor system has long been considered a pathway that promotes cell proliferation, survival and transformation and is thus a promoter of tumorigenesis. However, recent failure of clinical trials for IGF-1R inhibitors reveals the need for a better understanding of how this pat...
Main Authors: | Lauren M. Rota, Teresa L Wood |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2015.00092/full |
Similar Items
-
THE EMERGING ROLE OF INSULIN AND INSULIN-LIKE GROWTH FACTOR SIGNALING IN CANCER STEM CELLS
by: Roberta eMalaguarnera, et al.
Published: (2014-02-01) -
The Insulin Receptor: a New Target for Cancer Therapy
by: Antonino eBelfiore, et al.
Published: (2011-12-01) -
The Insulin/IGF system in colorectal cancer development and resistance to therapy
by: Paolo Giovanni Vigneri, et al.
Published: (2015-10-01) -
A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression
by: Martina Chrudinová, et al.
Published: (2024-02-01) -
Insulin Receptor Isoforms in Cancer
by: Veronica Vella, et al.
Published: (2018-11-01)